Results 251 to 260 of about 118,394 (314)
Association of a remote monitoring programme with all‐cause mortality and hospitalizations in patients with heart failure: National‐scale, real‐world evidence from a 3‐year propensity score analysis of the TELESAT‐HF study
European Journal of Heart Failure, EarlyView.Association of a remote monitoring programme (RMP) with all‐cause mortality and hospitalization in heart failure (HF) patients. COPD, chronic obstructive pulmonary oedema; HR, hazard ratio; ICU, intensive care unit; LTI, long‐term illness; RR, rate ratio; SoC, standard of care.Nicolas Girerd, Vanessa Barbet, Marie‐France Seronde, Hélène Benchimol, Annabelle Jagu, Jean‐Michel Tartière, Olivier Hanon, François Picard, Stéphane Lafitte, Magali Lemaitre, Nicolas Pages, Sophie Nisse‐Durgeat, Patrick Jourdain +12 morewiley +1 more sourceCardiovascular magnetic resonance‐estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR‐DM‐HF)
European Journal of Heart Failure, EarlyView.Abstract Aims
A cardiovascular magnetic resonance (CMR) approach to non‐invasively estimate left ventricular (LV) filling pressure was recently developed and shown to correlate with invasively measured pulmonary capillary wedge pressure (PCWP). We examined the association between CMR‐estimated PCWP (CMR‐PCWP) and other imaging and biomarker measures of Joanna Osmanska, Kieran F. Docherty, Colin Berry, Pardeep S. Jhund, Kenneth Mangion, Patrick B. Mark, John J.V. McMurray, Giles Roditi, Naveed Sattar, Mark C. Petrie, Ross T. Campbell, Matthew M.Y. Lee +11 morewiley +1 more sourceCirculating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study
European Journal of Heart Failure, EarlyView.Summary of the study design and key findings. The (+) and (−) signs mean that the variable has a positive or a negative association with growth differentiation factor‐15 (GDF‐15) levels in the fully adjusted model (age, gender, current smoker, body mass index, total cholesterol, systolic blood pressure and N‐terminal pro‐B‐type natriuretic peptide ...Luca Monzo, Constance Xhaard, João Pedro Ferreira, Guillaume Baudry, Zohra Lamiral, Kevin Duarte, Erwan Bozec, Jean‐Marc Boivin, Olivier Huttin, Patrick Rossignol, Faiez Zannad, Nicolas Girerd +11 morewiley +1 more sourceUpdate on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart
European Journal of Heart Failure, EarlyView.New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...Alessandra Ghigo, Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A. de Boer, Dimitrios Farmakis, Arantxa González, Stephane Heymans, Borja Ibáñez, Teresa López‐Fernández, Alexander R. Lyon, Piero Pollesello, Amina Rakisheva, Konstantinos Stellos, Katrin Streckfuss‐Bömeke, Carlo Gabriele Tocchetti, Thomas Thum, Peter van der Meer, Eva Van Rooij, Piotr Ponikowski, Marco Metra, Giuseppe Rosano, Sophie Van Linthout +22 morewiley +1 more sourceMinimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review
European Journal of Heart Failure, EarlyView.This systematic review included seven studies that reported the outcomes of minimization or withdrawal of oral pharmacotherapy in chronic heart failure (HF) patients with improved myocardial function. There is a dearth of existing evidence, which supports only loop diuretic withdrawal and possibly carvedilol monotherapy.Yuxiang Luo, Wenbin Xiao, Yusuf Z. Sener, Wouter C. Meijers, Robert M.A. van der Boon, Elfatih A. Hasabo, Osama Soliman, Rudolf A. de Boer, Kadir Caliskan +8 morewiley +1 more sourceFurosemide‐hydration matching with RenalGuard® in decompensated heart failure: an alternative way to use diuretics and saline
ESC Heart Failure, EarlyView.Massimo Mapelli, Filippo Maria Rubbo, Jeness Campodonico, Nicola Cosentino, Giancarlo Marenzi, Valentina Mantegazza, Filippo Trombara, Mateusz Sokolski, Piotr Ponikowski, Piergiuseppe Agostoni +9 morewiley +1 more source
